30 clinically reviewed articles, written and peer-reviewed by the HealthRX.com Medical Team.
Showing 30 of 30 clinical reviews.
Can you take alprostadil with acetaminophen? A clinician-reviewed guide covering pharmacokinetic overlap, hepatic metabolism, severity rating, dose adjustments, and monitoring recommendations.
Clinical guide to using alprostadil (Caverject or MUSE) with apixaban (Eliquis). Covers pharmacodynamic interaction mechanism, bleeding risk at the injection site, monitoring parameters, and dose-adjustment guidance.
A clinician-reviewed guide to the alprostadil and atorvastatin drug interaction, covering mechanism, severity, monitoring parameters, dose considerations, and patient counseling for men using both agents.
A clinical deep-dive into the pharmacodynamic interaction between alprostadil (Caverject/MUSE) and benzodiazepines, covering mechanism, severity, monitoring parameters, dose considerations, and patient counseling.
Clinical review of the alprostadil and bupropion drug interaction, covering CYP2D6 inhibition, blood pressure monitoring, seizure risk, dose adjustment, and patient counseling.
Clinical guide to the alprostadil and clopidogrel drug interaction, covering bleeding risk, mechanism, monitoring, dose adjustment, and when to consult your prescriber.
A physician-reviewed guide to the alprostadil and diphenhydramine drug interaction, covering mechanism, cardiovascular risks, anticholinergic effects, monitoring, and patient counseling for men using Caverject or MUSE.
A physician-reviewed guide to the pharmacokinetic and pharmacodynamic interactions between alprostadil (Caverject/MUSE) and estradiol HRT, including VTE risk, monitoring parameters, and clinical management.
A physician-reviewed guide to combining alprostadil (Caverject/MUSE) with finasteride for erectile dysfunction, covering mechanism, safety, monitoring, and dosing.
Can you take alprostadil with gabapentin? A physician-reviewed guide covering pharmacologic interaction mechanisms, blood pressure risks, monitoring protocols, and dose-adjustment strategies.
Does alprostadil interact with hormonal contraceptives? This MD-level guide covers mechanism, pharmacokinetics, clinical risk, monitoring, and patient counseling for Caverject and MUSE users.
Is it safe to take alprostadil with levothyroxine? A physician-reviewed guide covering pharmacokinetic mechanisms, monitoring protocols, dose timing, and clinical evidence for combining these medications.
Clinical review of the alprostadil and metformin drug interaction, including pharmacokinetic and pharmacodynamic considerations, safety data, monitoring recommendations, and dose-adjustment guidance for men using both medications.
Can you take alprostadil with ibuprofen or naproxen? A clinician-reviewed guide covering the pharmacodynamic overlap, bleeding risk, renal effects, monitoring protocols, and dose-adjustment strategies for combining Caverject or MUSE with NSAIDs.
Clinical guide to the alprostadil and opioid interaction, covering hypotension risk, pharmacodynamic mechanisms, monitoring protocols, and dose-adjustment strategies for patients on both medications.
Clinical analysis of the interaction between alprostadil (Caverject/MUSE) and proton pump inhibitors including omeprazole and pantoprazole. Covers pharmacokinetics, safety data, and monitoring recommendations.
Clinical guide to combining alprostadil (Caverject/MUSE) with prednisone: pharmacokinetic and pharmacodynamic interactions, monitoring parameters, dose adjustments, and patient counseling.
Clinical review of the alprostadil and pregabalin drug interaction, covering pharmacodynamic overlap, hypotension risk, monitoring parameters, and dose-adjustment guidance.
Clinical review of the drug interaction between alprostadil (Caverject/MUSE) and progesterone hormone replacement therapy, including mechanism, severity, monitoring, and dose adjustment guidance.
A physician-reviewed guide to the alprostadil and rivaroxaban drug interaction, covering pharmacodynamic bleeding risk, mechanism, monitoring, and safe use in men with erectile dysfunction on anticoagulation.
Clinical review of the alprostadil and rosuvastatin drug interaction, covering pharmacokinetic and pharmacodynamic mechanisms, severity classification, monitoring parameters, and patient counseling.
Can you take alprostadil (Caverject or MUSE) with sildenafil (Viagra)? Learn about the pharmacodynamic interaction, hypotension risk, dose adjustments, monitoring protocols, and what the clinical evidence says about combining these erectile dysfunction treatments.
A detailed clinical review of the alprostadil and simvastatin drug interaction, covering mechanism, severity, monitoring parameters, dose adjustment, and patient counseling based on FDA labels and primary literature.
Clinical guide to combining alprostadil (Caverject/MUSE) with SNRIs like venlafaxine and duloxetine. Covers mechanism, blood pressure risks, monitoring, dose adjustments, and patient counseling.
A physician-reviewed guide to the alprostadil and SSRI interaction, covering mechanism, severity, monitoring, dose adjustment, and patient counseling for men managing ED and depression together.
A physician-reviewed guide to the pharmacodynamic interaction between alprostadil (Caverject/MUSE) and tadalafil (Cialis), covering hypotension risk, priapism, monitoring, and dose-adjustment protocols.
A clinician-level review of the alprostadil and testosterone drug interaction, covering pharmacodynamic overlap, polycythemia risk, lipid effects, monitoring protocols, and dose-adjustment guidance.
Clinical guide to the alprostadil and trazodone drug interaction, covering mechanism, severity, monitoring parameters, dose adjustments, and patient counseling for men using both medications.
Board-reviewed guide to the alprostadil and warfarin drug interaction. Covers bleeding risk, pharmacokinetic and pharmacodynamic mechanisms, INR monitoring, dose adjustments, and clinical guidance for men on anticoagulation therapy.
Clinical guide to the alprostadil and zolpidem drug interaction, covering pharmacodynamic mechanisms, hypotension risk, dose timing, monitoring, and patient counseling.